| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 246.90M | 231.78M | 199.43M | 166.79M | 138.62M | 127.93M |
| Gross Profit | 129.85M | 122.92M | 104.01M | 65.36M | 55.56M | 49.93M |
| EBITDA | 64.05M | 57.26M | 79.27M | 34.58M | 30.26M | 24.36M |
| Net Income | 25.95M | 30.34M | 54.17M | 15.84M | 9.42M | 8.96M |
Balance Sheet | ||||||
| Total Assets | 321.54M | 323.48M | 281.87M | 283.76M | 271.65M | 266.01M |
| Cash, Cash Equivalents and Short-Term Investments | 10.84M | 14.72M | 10.01M | 13.29M | 10.15M | 8.62M |
| Total Debt | 89.19M | 68.97M | 32.55M | 77.25M | 74.99M | 70.95M |
| Total Liabilities | 153.31M | 138.07M | 96.01M | 134.48M | 127.22M | 116.95M |
| Stockholders Equity | 168.23M | 185.41M | 185.85M | 149.28M | 144.44M | 149.07M |
Cash Flow | ||||||
| Free Cash Flow | 34.33M | 33.63M | 35.42M | 26.13M | 18.10M | 26.42M |
| Operating Cash Flow | 35.56M | 41.82M | 42.93M | 31.58M | 27.44M | 29.32M |
| Investing Cash Flow | -22.00M | -21.86M | 29.17M | -13.76M | -9.37M | -3.61M |
| Financing Cash Flow | -12.29M | -15.25M | -75.39M | -14.69M | -16.54M | -31.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £113.25M | 10.13 | 20.23% | 3.00% | 16.79% | 26.31% | |
70 Outperform | £584.28M | 20.10 | 14.67% | 3.54% | 13.53% | -57.83% | |
65 Neutral | £282.27M | 6.43 | 25.81% | 4.65% | -2.79% | 37.33% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | £794.17M | 29.48 | 5.35% | 0.67% | 4.00% | -6.98% |